规格: | 98% |
分子量: | 422.9 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
Background:
(S)-(+)-Clopidogrel-d3is intended for use as an internal standard for the quantification of (S)-(+)-clopidogrel by GC- or LC-MS. (S)-(+)-Clopidogrel is the functional enantiomer of clopidogrel and a prodrug whose thiol metabolite antagonizes purine binding to the platelet purinergic receptor P2Y12(Ki= 316 nM in human platelets).1It is metabolized by the cytochrome P450 (CYP) isoform CYP2C19 in rat liver and inhibits ADP-induced platelet aggregationex vivo.2Formulations containing (S)-(+)-clopidogrel have been used in combination with aspirin to prevent vascular ischemic events in patients with acute coronary syndromes.
1.Savi, P., Labouret, C., Delesque, N., et al.P2Y12, a new platelet ADP receptor, target of clopidogrelBiochem. Bioph. Res. Commun.283(2)379-383(2001) 2.Quinn, M.J., and Fitzgerald, D.J.Ticlopidine and clopidogrelCirculation100(15)1667-1672(1999)